By Karen Roman Eliem Therapeutics, Inc. (Nasdaq: ELYM) said its new corporate name will be Climb Bio, Inc. and it will start trading at Nasdaq with the ticker symbol “CLYM” on Oct. 3. This rebranding reflects Climb’s laser-focused mission on...

By Karen Roman Aktis Oncology said it raised $175 million in Series B financing, led by RA Capital Management, with RTW Investments and Janus Henderson Investors as co-leads. The capital will contribute to the company’s radiopharmaceuticals pipeline including AKY-1189, its...

By Daniella Parra Vivani Medical said it received regulatory approval in Australia for its GLP-1 (exenatide) implant, aimed at treating obese and overweight individuals. The trial will evaluate the safety, tolerability and pharmacokinetic profile of the implant, which is designed...

By Daniella Parra Agendia said its FLEX Study has enrolled over 17,000 early-stage breast cancer patients from diverse ethnic and racial backgrounds, aiming to address racial and ethnic disparities in breast cancer treatment. The study is a large-scale, real-world evidence,...

By Karen Roman Kineticos Life Sciences said it has partnered with Orthobond, a biotechnology company focused on medical devices, through investment from the Kineticos AMR Accelerator Fund I. Kineticos strategic advisor Steve Favaloro will be joining Orthobond’s Board of Directors,...

By Daniella Parra Creyon Bio has added two prominent venture capitalists, Serge Messerlian from DCVC Bio and Shaquille Vayda from Lux Capital, to its Board of Directors, it said. The company said Messerlian has a background in hematology, oncology, and...

By Karen Roman Agilent Technologies, Inc. (NYSE: A) said it opened Biopharma CDx Services Lab in Carpinteria, California. The laboratory will contribute to drug development, therapeutics and precision medicine, as well as early clinical studies through regulatory approval, it said...

By Karen Roman Biotechnology company Medera Inc. said it entered a definitive merger agreement with Keen Vision Acquisition Corp. (Nasdaq: KVAC), with the combined company having an implied initial enterprise value of approximately $622.6 million. The transaction will close in...

By Daniella Parra Creyon Bio has received a U.S. patent for its AI-driven platform that designs safer and more effective oligonucleotide-based medicines (OBMs), it said. This company said the platform’s success includes advancing a program from concept to patient treatment...

By Karen Roman MOBILion Systems, Inc. said it appointed Rohit Khanna, Ph.D., to serve on its Board of Directors. Dr. Khanna is a life sciences executive with over three decades of experience in the analytical instrumentation industry, the company said in...